Bio-Techne Corp (TECH)
NASDAQ
Key stats Fiscal year 2026
Income statement
- Revenue
- 1,215,039,000 -0.4%
- Net income
- 181,862,000 147.8%
- Gross profit
- 799,071,000
- Operating income
- 251,890,000
- Earnings per share
- 1.17 148.9%
Growth and profitability
- Gross margin
- 65.77
- Operating margin
- 20.73
- Net margin
- 14.97
- Return on equity
- 8.63
- Return on assets
- 7.03
- Free cash flow margin
- 21.66
Balance sheet
- Total assets
- 2,586,726,000
- Shareholders' equity
- 2,108,221,000
- Cash and equivalents
- 264,712,000
- Current ratio
- 4.55
Cash flow and ratios
- Operating cash flow
- 292,073,000
- Free cash flow
- 263,223,000
Shareholder returns
- Dividend per share
- 0.32
- Dividends paid
- 49,916,000
- Share buybacks
- 41,675,000
- Shares outstanding
- 157,090,727
- Book value per share
- 13.42
Company information
- Headquarters
- Minneapolis, MN
- Exchange
- NASDAQ
- Fiscal year end
- 06-30
- Industry (SEC)
- Biological Products, (no Diagnostic Substances)
Fiscal year end: · Source: SEC EDGAR
Bio-Techne Corp trades on NASDAQ under the ticker symbol TECH. This page brings together its price chart, company profile, key financial figures and technical indicators.